Immunogenetic markers of clincial evolution of COVID-19

  • Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Total publications:1 publications

Grant number: 20/06471-9

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2023
  • Funder

    Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Principal Investigator

    N/A

  • Research Location

    Brazil
  • Lead Research Institution

    Faculdade de Medicina de São José do Rio Preto (FAMERP). Secretaria de Desenvolvimento Econômico (São Paulo - Estado)
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

mild and severe] and asymptomatic) favours the immunogenic understanding of humans in the face of SARS-CoV-2 infection and clinical evolution of COVID-19.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Asymptomatic SARS-CoV-2 Infection: Association Involving the HLA-B*15 Allele Group in Brazilian Individuals.